Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Drug Type
     • Market Snapshot, By Route of Administration
     • Market Snapshot, By Distribution Channel
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunity
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product Launches / Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger, Collaboration and Acquisitions Scenario
4. Global Ankylosing Spondylitis Market– Impact of Coronavirus (COVID-19) Pandemic
   • COVID-19 Epidemiology
   • Supply side and Demand Side Analysis
   • Economic Impart
5. Global Ankylosing Spondylitis Market, By Drug Type, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Disease-modifying Anti-rheumatic Drugs (DMARDs)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • TNF Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Corticosteroids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
6. Global Ankylosing Spondylitis Market, by Route of Administration, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Oral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
   • Parentral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
7. Global Ankylosing Spondylitis Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
8. Global Ankylosing Spondylitis Market, By Region, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, By Region, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, For Regions, 2017–2028
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country 2017 – 2028, (US$ Mn)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
       • U.K.
       • Germany
       • France
       • Italy
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
     • Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2017 – 2028, (US$ Mn)
       • North Africa
       • Central Africa
       • South Africa
9. Competitive Landscape
   • Heat Map Analysis
   • Market Share Analysis
     • Amgen Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • AbbVie Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Pfizer Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Novartis AG
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Bristol-Myers Squibb Company
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • CELGENE CORPORATION
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Eli Lilly and Company
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Cipla Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Emcure Pharmaceuticals
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Torrent Pharmaceuticals Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • UCB S.A.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Suzhou Zelgen Biopharmaceuticals Co., Ltd
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • HENGRUI USA
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
     • Johnson & Johnson Services, Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Strategies
   • Analyst Views
10. Section
    • Research Methodology
    • About us

*Browse 35 market data tables and 39 figures on "Global Ankylosing Spondylitis Market” - Global forecast to 2028